Literature DB >> 20930216

An automated high-content assay for tumor cell migration through 3-dimensional matrices.

Victoria Echeverria1, Ivar Meyvantsson, Allyson Skoien, Tracy Worzella, Casey Lamers, Steven Hayes.   

Abstract

High-content tumor cell migration assays in 3-dimensional (3D) extracellular matrix are a powerful tool for modeling and understanding the biology of this critical step in the process of metastasis. Currently available methods offer very limited throughput and are not amenable to studies of comparative pharmacology or small-scale screening. The authors present an automated approach to high-content tumor cell migration assays. A standard screening-sized plate with an array of microchannels was designed and constructed from common thermoplastics. After filling the channels with 3D matrix, cells were placed at one end of the channel, and migration into the channel was monitored via an imaging system. All liquid-handling steps were performed by standard liquid-handling robotics. Tumor cell migration in the channel was truly 3D and correlated with metastatic potential. The information-rich data from these assays were used to rank the potency of compounds inhibiting migration through 3D collagen as well as to gain additional insights into the compounds' activities related to cell health. This approach is compatible with a variety of multiparametric, morphological, and/or kinetic readouts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930216     DOI: 10.1177/1087057110378890

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  12 in total

1.  A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.

Authors:  Kim Wilkinson; Justin D Boyd; Marcie Glicksman; Kathryn J Moore; Joseph El Khoury
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

Review 2.  Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer.

Authors:  Shannon K Hughes-Alford; Douglas A Lauffenburger
Journal:  Curr Opin Cell Biol       Date:  2012-01-26       Impact factor: 8.382

Review 3.  Developments in preclinical cancer imaging: innovating the discovery of therapeutics.

Authors:  James R W Conway; Neil O Carragher; Paul Timpson
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

4.  Three-dimensional image cytometer based on widefield structured light microscopy and high-speed remote depth scanning.

Authors:  Heejin Choi; Dushan N Wadduwage; Ting Yuan Tu; Paul Matsudaira; Peter T C So
Journal:  Cytometry A       Date:  2014-10-28       Impact factor: 4.355

5.  High-Throughput Assessment of Mechanistic Toxicity of Chemicals in Miniaturized 3D Cell Culture.

Authors:  Pranav Joshi; Soo-Yeon Kang; Akshata Datar; Moo-Yeal Lee
Journal:  Curr Protoc Toxicol       Date:  2018-11-02

Review 6.  Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

Authors:  A Chen; M L Yarmush; T Maguire
Journal:  Curr Drug Metab       Date:  2012-07       Impact factor: 3.731

7.  Multizone paper platform for 3D cell cultures.

Authors:  Ratmir Derda; Sindy K Y Tang; Anna Laromaine; Bobak Mosadegh; Estrella Hong; Martin Mwangi; Akiko Mammoto; Donald E Ingber; George M Whitesides
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

Review 8.  High Content Imaging (HCI) on Miniaturized Three-Dimensional (3D) Cell Cultures.

Authors:  Pranav Joshi; Moo-Yeal Lee
Journal:  Biosensors (Basel)       Date:  2015-12-14

9.  Cell migration and invasion assays as tools for drug discovery.

Authors:  Keren I Hulkower; Renee L Herber
Journal:  Pharmaceutics       Date:  2011-03-11       Impact factor: 6.321

10.  Development of a high-throughput three-dimensional invasion assay for anti-cancer drug discovery.

Authors:  Nikki A Evensen; Jian Li; Jie Yang; Xiaojun Yu; Nicole S Sampson; Stanley Zucker; Jian Cao
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.